|
WO2008099060A2
|
|
Methods for the preparation of fispemifene from ospemifene
|
|
US2008021111A1
|
|
Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors
|
|
CA2628964A1
|
|
Formulations of fispemifene
|
|
CA2593335A1
|
|
The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
|
|
US2006030570A1
|
|
Method for treating cryptorchidism
|
|
BRPI0514701A
|
|
use of a selective estrogen receptor modulator, or an isomer, isomer mixture, metabolite or a pharmaceutically acceptable salt thereof
|
|
BRPI0510465A
|
|
liquid oral drug formulation in solution form and liquid or semi-solid oral drug formulation
|
|
EP1718288A1
|
|
Solid formulations of ospemifene
|
|
NZ536118A
|
|
Method for the inhibition of urogenital atrophy or for treatment or prevention of urogenital atrophy-related symptoms in women
|
|
EP1705169A2
|
|
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
|
